Price
$6.21
Decreased by -1.43%
Dollar Volume (20D)
867.75 K
ADR%
19.52
Market Cap.
230.73 M
Shares Float
53.35 M
Shares Outstanding
37.15 M
Beta
-0.11
Price / Earnings
-2.33
BPR
0.40
20D Range
3.37 6.82
50D Range
3.37 11.88
200D Range
3.37 11.88
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.